Iradimed (IRMD) Stock Statistics & Valuation Metrics

Iradimed has a market cap or net worth of $1.18B. The enterprise value is $1.12B.

Iradimed has 12,783,035 shares outstanding. The number of shares has decreased by -2.65% in one year.

Iradimed’s return on equity (ROE) is 0.24 and return on invested capital (ROIC) is 21.02%.

The current PE Ratio of Iradimed is 52.9. Iradimed’s PEG ratio is 3.35.

In the last 12 months, Iradimed had revenue of 83.81M and earned 22.48M in profits. Earnings per share was 1.77.

In the last 12 months, operating cash flow was 28.94M and capital expenditures -4.85M, giving a free cash flow of 24.10M billion.

Iradimed pays an annual dividend of $0.5, resulting in a dividend yield of 1.22%

Iradimed upcoming earnings date is Jul 30, 2026, Before Open (Confirmed).

Iradimed as a current ratio of 7.98, with Debt / Equity ratio of 0.00%

In the past 12 months, Iradimed has paid 5.88M in taxes.

Iradimed EV to EBITDA ratio is 41.59, with an EV/FCF ratio of 69.05.

Iradimed has $56.37M in cash and marketable securities with $0.00 in debt, giving a net cash position of $56.37M billion.

Gross margin is 76.84%, with operating margin of 31.20%, and net profit margin of 26.82%.

The average price target for Iradimed is $116.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy